Artal Group S.A. - Q4 2015 holdings

$5.33 Billion is the total value of Artal Group S.A.'s 81 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 44.7% .

 Value Shares↓ Weighting
BUFF  BLUE BUFFALO PET PRODS INC$2,151,417,000
+4.5%
114,987,5470.0%40.39%
-12.2%
LXRX SellLEXICON PHARMACEUTICALS INC$765,564,000
+23.9%
57,517,977
-0.0%
14.37%
+4.1%
WW  WEIGHT WATCHERS INTL INC NEW$671,307,000
+257.4%
29,443,3000.0%12.60%
+200.3%
GS BuyGOLDMAN SACHS GROUP INCcall$135,173,000
+55.6%
750,000
+50.0%
2.54%
+30.7%
BIIB SellBIOGEN INCcall$107,223,000
-8.1%
350,000
-12.5%
2.01%
-22.8%
WMT  WAL-MART STORES INCcall$102,065,000
-5.5%
1,665,0000.0%1.92%
-20.6%
CELG BuyCELGENE CORPcall$95,808,000
+36.3%
800,000
+23.1%
1.80%
+14.5%
MET BuyMETLIFE INCcall$72,315,000
+22.7%
1,500,000
+20.0%
1.36%
+3.1%
NewBANK AMER CORPcall$67,320,0004,000,000
+100.0%
1.26%
NewAPPLE INCcall$63,156,000600,000
+100.0%
1.19%
INCY BuyINCYTE CORP$61,817,000
+14.3%
570,000
+16.3%
1.16%
-4.0%
JPM SellJPMORGAN CHASE & COcall$56,126,000
-29.2%
850,000
-34.6%
1.05%
-40.5%
SPY NewSPDR S&P 500 ETF TRcall$50,968,000250,000
+100.0%
0.96%
ALNY BuyALNYLAM PHARMACEUTICALS INC$44,717,000
+27.9%
475,000
+9.2%
0.84%
+7.4%
BMY  BRISTOL MYERS SQUIBB COcall$34,395,000
+16.2%
500,0000.0%0.65%
-2.3%
GM  GENERAL MTRS COcall$34,010,000
+13.3%
1,000,0000.0%0.64%
-4.9%
IBB NewISHARES TRcall$33,833,000100,000
+100.0%
0.64%
MS  MORGAN STANLEYcall$31,810,000
+1.0%
1,000,0000.0%0.60%
-15.2%
GILD  GILEAD SCIENCES INCcall$30,357,000
+3.1%
300,0000.0%0.57%
-13.4%
TEVA  TEVA PHARMACEUTICAL INDS LTDcall$29,538,000
+16.3%
450,0000.0%0.55%
-2.5%
MA  MASTERCARD INCcl a$29,208,000
+8.0%
300,0000.0%0.55%
-9.3%
BMRN SellBIOMARIN PHARMACEUTICAL INC$28,809,000
-37.8%
275,000
-37.5%
0.54%
-47.7%
NKTR SellNEKTAR THERAPEUTICS$26,960,000
+36.7%
1,600,000
-11.1%
0.51%
+14.7%
MRK  MERCK & CO INC NEWcall$26,410,000
+6.9%
500,0000.0%0.50%
-10.1%
QCOM  QUALCOMM INCcall$24,993,000
-7.0%
500,0000.0%0.47%
-21.8%
BABA SellALIBABA GROUP HLDG LTDcall$24,381,000
-17.3%
300,000
-40.0%
0.46%
-30.5%
BABA  ALIBABA GROUP HLDG LTDsponsored ads$24,381,000
+37.8%
300,0000.0%0.46%
+15.9%
BLUE BuyBLUEBIRD BIO INC$23,119,000
-14.2%
360,000
+14.3%
0.43%
-27.9%
LNKD SellLINKEDIN CORP$22,508,000
-5.3%
100,000
-20.0%
0.42%
-20.3%
YUM BuyYUM BRANDS INC$21,915,000
+82.7%
300,000
+100.0%
0.41%
+53.4%
IONS NewIONIS PHARMACEUTICALS INC$21,676,000350,000
+100.0%
0.41%
KITE SellKITE PHARMA INC$21,567,000
-0.7%
350,000
-10.3%
0.40%
-16.5%
ENDP SellENDO INTL PLCcall$18,366,000
-47.0%
300,000
-40.0%
0.34%
-55.4%
YUM  YUM BRANDS INCcall$18,263,000
-8.6%
250,0000.0%0.34%
-23.3%
AGIO BuyAGIOS PHARMACEUTICALS INC$17,853,000
+12.4%
275,000
+22.2%
0.34%
-5.6%
NewBANK AMER CORP$16,830,0001,000,000
+100.0%
0.32%
ARRY  ARRAY BIOPHARMA INC$15,656,000
-7.5%
3,710,0000.0%0.29%
-22.2%
GE SellGENERAL ELECTRIC COcall$15,575,000
-69.1%
500,000
-75.0%
0.29%
-74.1%
MBBYF NewMOBILEYE N V AMSTELVEEN$14,798,000350,000
+100.0%
0.28%
MU  MICRON TECHNOLOGY INCcall$14,160,000
-5.5%
1,000,0000.0%0.27%
-20.6%
NewAMERICAN EXPRESS COcall$13,910,000200,000
+100.0%
0.26%
GM SellGENERAL MTRS CO$13,604,000
+0.7%
400,000
-11.1%
0.26%
-15.6%
V NewVISA INC$13,571,000175,000
+100.0%
0.26%
JPM NewJPMORGAN CHASE & CO$13,206,000200,000
+100.0%
0.25%
C SellCITIGROUP INCcall$12,938,000
-52.6%
250,000
-54.5%
0.24%
-60.2%
CELG NewCELGENE CORP$11,976,000100,000
+100.0%
0.22%
LC SellLENDINGCLUB CORP$11,879,000
-23.6%
1,075,000
-8.5%
0.22%
-35.7%
XBI SellSPDR SERIES TRUSTcall$10,530,000
-62.4%
150,000
-66.7%
0.20%
-68.4%
BMRN  BIOMARIN PHARMACEUTICAL INCcall$10,476,000
-0.5%
100,0000.0%0.20%
-16.2%
TWX  TIME WARNER INCcall$9,701,000
-5.9%
150,0000.0%0.18%
-20.9%
MS BuyMORGAN STANLEY$9,543,000
+21.2%
300,000
+20.0%
0.18%
+1.7%
KITE  KITE PHARMA INCcall$9,243,000
+10.7%
150,0000.0%0.17%
-7.0%
3106PS NewDELPHI AUTOMOTIVE PLC$8,573,000100,000
+100.0%
0.16%
JUNO SellJUNO THERAPEUTICS INC$8,354,000
-12.6%
190,000
-19.1%
0.16%
-26.6%
QCOM NewQUALCOMM INC$8,223,000164,500
+100.0%
0.15%
CCXI  CHEMOCENTRYX INC$7,290,000
+33.9%
900,0000.0%0.14%
+12.3%
AGIO NewAGIOS PHARMACEUTICALS INCcall$6,492,000100,000
+100.0%
0.12%
CLLS BuyCELLECTIS S Asponsored ads$6,516,000
+97.8%
210,000
+68.0%
0.12%
+64.9%
RXDX  IGNYTA INC$6,365,000
+52.6%
475,0000.0%0.12%
+28.0%
IONS NewIONIS PHARMACEUTICALS INCcall$6,193,000100,000
+100.0%
0.12%
MCRB SellSERES THERAPEUTICS INC$6,141,000
+3.6%
175,000
-12.5%
0.12%
-12.9%
CLDX  CELLDEX THERAPEUTICS INC NEW$5,880,000
+48.7%
375,0000.0%0.11%
+25.0%
INCY NewINCYTE CORPcall$5,423,00050,000
+100.0%
0.10%
BTX  BIOTIME INC$5,256,000
+36.7%
1,282,0500.0%0.10%
+15.1%
DAL NewDELTA AIR LINES INC DEL$5,069,000100,000
+100.0%
0.10%
JMEI  JUMEI INTL HLDG LTDsponsored adr$4,530,000
-8.2%
500,0000.0%0.08%
-22.7%
NK BuyNANTKWEST INC$3,899,000
+94.4%
225,000
+28.6%
0.07%
+62.2%
SRPT NewSAREPTA THERAPEUTICS INCcall$3,858,000100,000
+100.0%
0.07%
LC  LENDINGCLUB CORPcall$3,591,000
-16.5%
325,0000.0%0.07%
-30.2%
BLUE  BLUEBIRD BIO INCcall$3,211,000
-24.9%
50,0000.0%0.06%
-37.5%
RGNX BuyREGENXBIO INC$2,656,000
+2.7%
160,000
+36.3%
0.05%
-13.8%
AGEN  AGENUS INC$2,497,000
-1.3%
550,0000.0%0.05%
-17.5%
IRWD  IRONWOOD PHARMACEUTICALS INC$2,514,000
+11.2%
216,8790.0%0.05%
-6.0%
DMTX NewDIMENSION THERAPEUTICS INC$1,974,000175,000
+100.0%
0.04%
PARNF  PARNELL PHARMACEUT HLDGS LTD$1,940,000
+12.8%
500,0000.0%0.04%
-5.3%
SPNC  SPECTRANETICS CORP$1,506,000
+27.7%
100,0000.0%0.03%
+7.7%
ARRY  ARRAY BIOPHARMA INCcall$1,266,000
-7.5%
300,0000.0%0.02%
-22.6%
XOMA  XOMA CORP DELcall$532,000
+76.7%
400,0000.0%0.01%
+42.9%
CERE  CERES INC$338,000
-69.4%
1,024,0200.0%0.01%
-76.0%
CLCD  COLUCID PHARMACEUTICALS INC$47,000
+113.6%
5,5750.0%0.00%
JMEI ExitJUMEI INTL HLDG LTDcall$0-150,000
-100.0%
-0.03%
HLI ExitHOULIHAN LOKEY INCcl a$0-75,000
-100.0%
-0.04%
A104PS ExitHILTON WORLDWIDE HLDGS INC$0-100,000
-100.0%
-0.05%
ALNY ExitALNYLAM PHARMACEUTICALS INCcall$0-50,000
-100.0%
-0.09%
ISIS ExitISIS PHARMACEUTICALS INCcall$0-100,000
-100.0%
-0.09%
EEM ExitISHARES TRcall$0-250,000
-100.0%
-0.18%
AMZN ExitAMAZON COM INCcall$0-25,000
-100.0%
-0.29%
BAC ExitBANK AMER CORP$0-1,000,000
-100.0%
-0.35%
CCI ExitCROWN CASTLE INTL CORP NEWcall$0-200,000
-100.0%
-0.35%
ISIS ExitISIS PHARMACEUTICALS INC$0-400,000
-100.0%
-0.36%
MCD ExitMCDONALDS CORPcall$0-200,000
-100.0%
-0.44%
AAPL ExitAPPLE INCcall$0-200,000
-100.0%
-0.49%
AXP ExitAMERICAN EXPRESS COcall$0-450,000
-100.0%
-0.74%
GOOG ExitGOOGLE INCcall$0-60,000
-100.0%
-0.82%
BAC ExitBANK AMER CORPcall$0-3,000,000
-100.0%
-1.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AGENUS INC42Q3 20231.9%
IRONWOOD PHARMACEUTICALS INC42Q3 20230.3%
ALNYLAM PHARMACEUTICALS INC37Q3 20235.1%
LEXICON PHARMACEUTICALS INC34Q3 202320.6%
AMICUS THERAPEUTICS INC30Q3 20232.7%
BEIGENE LTD28Q3 20237.4%
BK OF AMERICA CORP28Q1 20214.3%
SAGE THERAPEUTICS INC28Q2 20231.9%
AGIOS PHARMACEUTICALS INC28Q2 20201.1%
NEKTAR THERAPEUTICS27Q2 20201.3%

View Artal Group S.A.'s complete holdings history.

Latest significant ownerships (13-D/G)
Artal Group S.A. Q4 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
WEIGHT WATCHERS INTERNATIONAL INCFebruary 13, 201529,443,30051.9%

View Artal Group S.A.'s complete significant-ownership history.

Latest filings
TypeFiled
42024-03-25
42024-03-13
42024-02-29
13F-HR2024-02-09
13F-HR2023-11-13
42023-10-16
13F-HR2023-08-11
42023-06-22
32023-06-15
42023-06-05

View Artal Group S.A.'s complete filings history.

Compare quarters

Export Artal Group S.A.'s holdings